Thursday, 24 August 2017

Lupin receives FDA approval for Fluocinonide Topical Solution

26 July 2017 | News

It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses

Source: Pixabay

Source: Pixabay

Pharma Major Lupin Limited recently announced that it has received final approval for its Fluocinonide Topical Solution USP, 0.05% from the United States Food and Drug Administration (FDA) to market a generic version of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution USP, 0.05%.

Lupin’s Fluocinonide Topical Solution USP, 0.05% is AT rated generic equivalent of County Line Pharmaceuticals, LLC’s Fluocinonide Topical Solution USP, 0.05%.

It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account





Survey Box

Are private sector's profits in healthcare soaring in India?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls